Skip to content
Search

Latest Stories

Indian great Ashwin joins Worcestershire

Indian spinner Ravichandran Ashwin will play for Worcestershire for the rest of their County Championship campaign, it was revealed Tuesday (15).

The 30-year-old, who took 17 wickets on the recent tour of Sri Lanka as India completed their first three-Test series sweep on foreign soil on Monday (14), will replace Australian John Hastings as the county's overseas player in a coup for the second-tier side.


The county will hope Ashwin, ranked number three in the bowler's Test world rankings and second in the all-rounder lists, propels them to promotion in their final four matches.

Ashwin will be the first Indian player to play for Worcestershire since Zaheer Khan resurrected his international career after a superb season with them in 2006.

"Ravi is a fantastic international cricketer who is currently in terrific form with his game," purred Worcestershire's chief executive Steve Rhodes in a statement released by the club.

"He is ranked in the top three as a bowler in Test cricket, is a wonderful all-rounder who can bat six and scores hundreds in Test cricket.

"It is unlucky for John Hastings with his injury but Ravi is a wonderful cricketer for us to have at a crucial point in our season.

"It is a really important last few games in the Championship and to have someone of his class is a huge boost for the club."

Ashwin has taken 286 wickets in 51 Tests, including five wickets in an innings on 26 occasions, 150 ODI wickets and 52 in T20Is.

Ashwin is also a force with the bat and has scored 2,004 Test runs at an average of 32.85 with four centuries and 11 fifties, and had been an opening batsman before turning to off-spin.

Worcestershire presently occupy the second and last spot for promotion to the first division, 15 points clear of third-placed Northamptonshire, whilst Sussex and Kent are a further two points adrift.

More For You

pharmacy

The UK spends just 9 per cent of healthcare budgets on medicines while patients face growing access gaps.

iStock

UK calls for new pharmaceutical investment to strengthen life sciences

Highlights

  • UK life sciences sector contributed £17.6bn GVA in 2021 and supports 126,000 high-skilled jobs.
  • Inward life sciences FDI fell by 58 per cent from £1,897m in 2021 to £795m in 2023.
  • Experts warn NHS underinvestment and NICE pricing rules are deterring innovation and patient access.

Investment gap

Britain is seeking to attract new pharmaceutical investment as part of its plan to strengthen the life sciences sector, Chancellor Rachel Reeves said during meetings in Washington this week. “We do need to make sure that we are an attractive place for pharmaceuticals, and that includes on pricing, but in return for that, we want to see more investment flow to Britain,” Reeves told reporters.

Recent ABPI report, ‘Creating the conditions for investment and growth’, The UK’s pharmaceutical industry is integral to both the country’s health and growth missions, contributing £17.6 billion in direct gross value added (GVA) annually and supporting 126,000 high-skilled jobs across the nation. It also invests more in research and development (R&D) than any other sector. Yet inward life sciences foreign direct investment (FDI) fell by 58per cent, from £1,897 million in 2021 to £795 million in 2023, while pharmaceutical R&D investment in the UK lagged behind global growth trends, costing an estimated £1.3 billion in lost investment in 2023 alone.

Keep ReadingShow less